• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chapter 4.1: Treatment of CKD-MBD targeted at lowering high serum phosphorus and maintaining serum calcium.

出版信息

Kidney Int. 2009 Aug;76113:S50-99. doi: 10.1038/ki.2009.192.

DOI:10.1038/ki.2009.192
PMID:26746397
Abstract
摘要

相似文献

1
Chapter 4.1: Treatment of CKD-MBD targeted at lowering high serum phosphorus and maintaining serum calcium.第4.1章：针对降低高血清磷和维持血清钙水平的慢性肾脏病-矿物质和骨异常的治疗
Kidney Int. 2009 Aug;76113:S50-99. doi: 10.1038/ki.2009.192.
2
The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.早期慢性肾脏病-矿物质骨代谢紊乱（CKD-MBD）的病理生理学及在大鼠中对磷酸盐结合剂的反应。
J Bone Miner Res. 2011 Nov;26(11):2672-81. doi: 10.1002/jbmr.485.
3
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).医生对慢性肾脏病-矿物质和骨异常（CKD-MBD）当前评估与治疗的态度调查
Saudi J Kidney Dis Transpl. 2010 Jan;21(1):93-101.
4
Phosphate binders in moderate chronic kidney disease: where do we stand?中度慢性肾脏病中的磷结合剂：我们目前的状况如何？
J Nephrol. 2013 Nov-Dec;26(6):993-1000. doi: 10.5301/jn.5000258. Epub 2013 Mar 25.
5
Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?慢性肾脏病矿物质和骨异常（CKD-MBD）中磷潴留/高磷血症的预防和控制：何为正常、何时开始以及如何治疗？
Clin J Am Soc Nephrol. 2011 Feb;6(2):440-6. doi: 10.2215/CJN.05130610. Epub 2011 Feb 3.
6
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病（未透析）患者矿物质代谢的变化
Nefrologia. 2008;28 Suppl 3:67-78.
7
Association of disorders in mineral metabolism with progression of chronic kidney disease.矿物质代谢紊乱与慢性肾脏病进展的关联
Clin J Am Soc Nephrol. 2006 Jul;1(4):825-31. doi: 10.2215/CJN.02101205. Epub 2006 May 17.
8
Calcium metabolism in health and disease.钙代谢与健康和疾病。
Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S23-30. doi: 10.2215/CJN.05910809.
9
Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease.支持（早期）慢性肾脏病患者肠内钙净吸收严重受损的证据。
Am J Nephrol. 2012;35(5):434-41. doi: 10.1159/000338299. Epub 2012 Apr 23.
10
Prognostic role of the product of serum calcium and phosphorus concentrations in dogs with chronic kidney disease: 31 cases (2008-2010).血清钙磷浓度乘积在慢性肾病犬中的预后作用：31例病例（2008 - 2010年）
J Am Vet Med Assoc. 2014 Nov 15;245(10):1135-40. doi: 10.2460/javma.245.10.1135.

引用本文的文献

1
Prevalence and outcomes associated with hypocalcaemia and hypercalcaemia among pre-dialysis chronic kidney disease patients with mineral and bone disorder.矿物质和骨代谢紊乱的透析前慢性肾脏病患者中低钙血症和高钙血症的患病率及其结局。
Singapore Med J. 2024 Aug 1;65(8):421-429. doi: 10.4103/singaporemedj.SMJ-2021-391. Epub 2022 Nov 2.
2
Analysis of the parathyroid function in maintenance hemodialysis patients from Changchun, China.中国长春维持性血液透析患者甲状旁腺功能分析。
Chronic Dis Transl Med. 2017 Aug 7;3(3):181-185. doi: 10.1016/j.cdtm.2017.07.001. eCollection 2017 Sep.
3
The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.
慢性肾脏病-矿物质与骨异常（CKD-MBD）：病理生理学进展
Bone. 2017 Jul;100:80-86. doi: 10.1016/j.bone.2017.01.023. Epub 2017 Jan 22.
4
Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.帕立骨化醇与活性非选择性维生素D受体激动剂治疗慢性肾脏病继发性甲状旁腺功能亢进的比较：一项随机对照试验的系统评价和荟萃分析
Int Urol Nephrol. 2016 Apr;48(4):571-84. doi: 10.1007/s11255-015-1195-6. Epub 2016 Jan 9.
5
Pathophysiology of the chronic kidney disease-mineral bone disorder.慢性肾脏病-矿物质和骨异常的病理生理学
Curr Opin Nephrol Hypertens. 2015 Jul;24(4):303-9. doi: 10.1097/MNH.0000000000000132.
6
Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.终末期肾病中的磷平衡：针对低显性隐匿池的饮食、透析和磷结合剂。
J Nephrol. 2015 Aug;28(4):415-29. doi: 10.1007/s40620-014-0142-4. Epub 2014 Sep 23.
7
Cost effectiveness of paricalcitol versus cinacalcet with low-dose vitamin D for management of secondary hyperparathyroidism in haemodialysis patients in the USA.在美国血液透析患者中，用低剂量维生素 D 治疗继发性甲状旁腺功能亢进症时，帕立骨化醇与西那卡塞的成本效益比较。
Clin Drug Investig. 2014 Feb;34(2):107-15. doi: 10.1007/s40261-013-0151-4.
8
Which vitamin D in CKD-MBD? The time of burning questions.维生素 D 在 CKD-MBD 中的应用：燃眉之急。
Biomed Res Int. 2013;2013:864012. doi: 10.1155/2013/864012. Epub 2013 Aug 7.
9
Hyperparathyroidism in chronic kidney disease: complexities within the commonplace.慢性肾脏病中的甲状旁腺功能亢进症：常见病症中的复杂性。
Clin Med (Lond). 2012 Aug;12(4):333-7. doi: 10.7861/clinmedicine.12-4-333.
10
Discriminants of prevalent fractures in chronic kidney disease.慢性肾脏病患者骨折的鉴别诊断。
J Am Soc Nephrol. 2011 Aug;22(8):1560-72. doi: 10.1681/ASN.2010121275. Epub 2011 Jul 22.